Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy

Overview of attention for article published in Clinical Journal of The American Society of Nephrology, July 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 66 X users

reddit: 1 Redditor

Readers on

mendeley: 20 Mendeley

So far, Altmetric has seen 68 X posts from 66 X users, with an upper bound of 109,614 followers.

Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy 👉https://t.co/KrSYK6Levz @CJASN #PLA2R #Risk #MembranousNephropathy https://t.co/k5yA6wsPPB

RT @CJASN: KDIGO guidelines recommend following anti-PLA2R antibody levels as a marker of treatment response in membranous nephropathy. Thi…

RT @abdelhamed012: Anti-PLA2R Antibody Levels and Clinical Risk Factors for... : Clinical Journal of the American Society of Nephrology htt…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 64 additional X posts.